Anuh Pharma Ltd Financial Statements & Historical Data

Updated NSE: ANUHPHRBSE: 506260
Report details
Last Updated:
Author: |Social: XLinkedIn

Anuh Pharma Ltd: Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 4.3% to ₹194 crore against Jun 2025. Net profit rose 37.5% to ₹11 crore against the same period a year earlier. Operating margin rose from 5.4% to 8.2% (2.9 percentage points higher). A reported annual profit of ₹41 crore coincided with an operating cash outflow of ₹3.00 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Calculated from the stored statements below · Reporting periods remain separate
COMPANY FINANCIAL DATA

Market snapshot

Stored figures, not live quotes. Price record: 15 October 2026, 10:20 pm +05:30. Financial reporting periods are shown in the tables below.

Stored share price83.7₹ per share
Reported P/E19.0Times
Book value per share35.1₹ per share
Reported ROCE14.9 %Reported return

Stored market and accounting figures

Price record: 15 October 2026, 10:20 pm +05:30. Not a live quote.

MeasureStored figure
Market Cap837 Cr.
Current Price83.7
High / Low99.5/66.7
Stock P/E19.0
Book Value35.1
Dividend Yield1.79 %
ROCE14.9 %
ROE10.7 %
Face Value5.00

Market cap is in ₹ crore; prices and per-share values are in ₹. P/E is a multiple; yield, ROCE and ROE are percentages. Book value is an accounting figure, not an estimate of the share's investment value.

Data sources and reporting basis

Sources: Company data source. Check the company filings linked by the source for the reporting basis and exceptional items.

Different tables can have different reporting dates and accounting bases. Verify the company filings before comparing figures. Missing data is not treated as zero.

How Getaka handles sources, dates and corrections. Page revision dates describe the page, not the age of every financial figure.

DAILY STORED OBSERVATIONS

Share price history

₹ per share

Last stored price for each available date, not a live quote or an official closing-price series. Missing dates are not filled. Verify corporate-action adjustments against the source.

Chart loads as you scroll.

EARNINGS

Quarterly performance

Jun 2026

Earnings grew faster than sales in the quarter ending Jun 2026. Sales rose 4.3% to ₹194 crore against Jun 2025. Net profit rose 37.5% to ₹11 crore against the same period a year earlier. Operating margin rose from 5.4% to 8.2% (2.9 percentage points higher). More operating profit was retained from each rupee of sales; check whether that improvement holds across other reporting periods.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Quarterly statementAll reported figures · use a chart icon for peer comparison

Quarterly Chart Table

MetricJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales 161150172164138166160198186186197202194
Expenses 148132148145127149145179176174178182178
Operating Profit 14182419111715191012192016
OPM % 9%12%14%12%8%10%9%9%6%6%10%10%8%
Other Income 32434311312-13
Interest 0000000000000
Depreciation 2222222333332
Profit before tax 15182520121813171110181617
Tax % 24%23%24%22%22%17%22%28%24%23%25%25%32%
Net Profit 121419151015101288131211
EPS in Rs 1.171.381.911.530.951.501.031.240.830.761.341.171.14

Last Updated: September 29, 2026, 8:47 am

EARNINGS

Annual performance

Mar 2026

Higher sales were accompanied by lower earnings in the year ending Mar 2026. Sales rose 16.6% to ₹772 crore against Mar 2025. Net profit fell 12.8% to ₹41 crore against the same period a year earlier. Operating margin fell from 9.4% to 8.0% (1.3 percentage points lower). Less operating profit was retained from each rupee of sales; compare the expense rows before attributing the change to a cause.

Sales, expenses & profits

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

PER-SHARE EARNINGS

Earnings per share

Reported annual earnings per share use ₹ per share, while the earnings charts use ₹ crore. Changes in share count and corporate actions can affect the comparison between years.

Earnings per share

₹ per share

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Annual statementAll reported figures · use a chart icon for peer comparison

Profit & Loss Chart Table

Last Updated: October 12, 2026, 5:20 am

MetricMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales 284326206238321307432487527647662772779
Expenses 253289183220291284387439476571600709712
Operating Profit 31382318302345475276626267
OPM % 11%12%11%8%9%8%10%10%10%12%9%8%9%
Other Income 548754115612945
Interest 1110112211110
Depreciation 322227151210991111
Profit before tax 32382823321939394778615460
Tax % 31%32%27%29%28%25%26%22%24%23%22%24%
Net Profit 22262017231428313660474144
EPS in Rs 2.192.572.001.652.331.432.843.053.615.994.734.104.41
Dividend Payout % 27%24%31%42%29%48%26%29%28%21%16%37%
Year-on-year profit growth table

YoY Net Profit Growth

Year2015-20162016-20172017-20182018-20192019-20202020-20212021-20222022-20232023-20242024-20252025-2026
YoY Net Profit Growth (%)18.18%-23.08%-15.00%35.29%-39.13%100.00%10.71%16.13%66.67%-21.67%-12.77%
Change in YoY Net Profit Growth (%)0.00%-41.26%8.08%50.29%-74.42%139.13%-89.29%5.41%50.54%-88.33%8.90%

Growth

Compounded Sales Growth
10 Years:9%
5 Years:17%
3 Years:11%
TTM:14%
Compounded Profit Growth
10 Years:7%
5 Years:26%
3 Years:13%
TTM:-20%
Stock Price CAGR
10 Years:2%
5 Years:-3%
3 Years:21%
1 Year:-17%
Return on Equity
10 Years:14%
5 Years:15%
3 Years:16%
Last Year:13%

Last Updated: September 5, 2025, 2:21 pm

CASH & FUNDING

Balance sheet

Mar 2026

Reported borrowings stood at ₹0.00 crore in Mar 2026. They decreased from ₹11 crore in Mar 2025 (100.0% lower). Read the borrowing notes, repayment schedule and cash-flow statement together; the borrowing balance alone does not establish liquidity or repayment capacity.

Reserves & borrowings

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Balance-sheet statementAll reported figures · use a chart icon for peer comparison

Balance Sheet Data Table

Last Updated: May 25, 2026, 4:00 am

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital 41313131313252525252550
Reserves 97107128137152150166189216266301302
Borrowings 020244514413110
Other Liabilities 6771485771119128129163152170205
Total Liabilities 168193189209240326333347405446507557
Fixed Assets 91817172184716153495857
CWIP 0006340000000
Investments 4343706639803143919710684
Other Assets 116131101120147163230243261300342416
Total Assets 168193189209240326333347405446507557
CASH & FUNDING

Cash generation

Mar 2026

Operating activities used ₹3.00 crore in Mar 2026. Reported free cash flow for the same period was −₹11 crore. Negative operating cash flow means cash left the operating cycle; examine receivables, working capital and the reconciliation in the company filing before attributing a cause. A reported annual profit of ₹41 crore coincided with an operating cash outflow of ₹3.00 crore in the year ending Mar 2026; the cash-flow reconciliation is important context for the earnings.

Operating & free cash flow

₹ crore

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Cash-flow statementAll reported figures · use a chart icon for peer comparison

Cash Flows

MonthMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity + 1916262749-1929541337-3
Cash from Investing Activity + -12-5-2023-7752-8-431-2018
Cash from Financing Activity + -8-9-4-5-722-33-19-12-9-5-26
Net Cash Flow -122-13-502-2512-12
Free Cash Flow 18625-5-2213-252752817-11
CFO/OP 96%78%149%49%56%232%-20%80%130%42%78%16%
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit 96%78%149%49%56%232%-20%80%130%42%78%16%
Free cash flowAll reported figures · use a chart icon for peer comparison

Free Cash Flow Table

Free cash flow reported in the stored cash-flow statement (₹ Cr)
PeriodMar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Free Cash Flow18.006.0025.00-5.00-22.0013.00-25.0027.0052.008.0017.00-11.00

This table and the chart use the Free Cash Flow row from the same stored cash-flow statement. Free cash flow generally measures operating cash flow after capital expenditure; check the source definition and reporting basis. It is not operating profit minus borrowings.

OPERATING CYCLE

Capital efficiency

Mar 2025

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Working-capital days were 68 in Mar 2025. That is 1 days lower than the same annual period a year earlier. Compare collection, inventory and payment cycles within this feed to understand the movement; these measures do not identify the cause by themselves.

Working capital

Days

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

CAPITAL RETURNS

Returns on capital & equity

Financial efficiency feed. Source: www.screener.in. Check the source for the accounting basis. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Returns on capital & equity

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Efficiency tableAll reported figures · use a chart icon for peer comparison

Financial Efficiency Data Table

MonthMar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Debtor Days 1028884100109859690102118107119
Inventory Days 332735726464989077665754
Days Payable 102797710210589166133117139105115
Cash Conversion Cycle 333642706861284862465859
Working Capital Days 424348798065-105768616968
ROCE %31%33%35%19%14%19%10%16%18%19%26%17%
SHAREHOLDERS

Ownership trends

Jun 2026

Promoters held 71.79% in Jun 2026. Their share was 1.88 percentage points higher than in Jun 2025. Ownership percentages can change through share issuance as well as transactions. Check exchange disclosures for the explanation and any pledging; the percentage alone is not evidence of investor conviction. FIIs held 0.01% in Jun 2026, 0.03 percentage points below their holding in Jun 2025. DIIs held 0.00% in Jun 2026, unchanged from their holding in Jun 2025.

Shareholding comparison

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

SHAREHOLDER PARTICIPATION

Shareholder count

Shareholder count

Shareholders

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Ownership tableAll reported figures · use a chart icon for peer comparison

Shareholding Pattern

MonthSep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters 70.59%69.94%69.91%69.91%69.91%69.91%69.91%69.91%71.81%71.81%71.79%71.79%
FIIs 0.00%0.00%0.03%0.03%0.02%0.02%0.04%0.04%0.00%0.00%0.05%0.01%
DIIs 0.00%0.00%0.10%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Public 29.40%30.05%29.96%30.05%30.06%30.07%30.04%30.04%28.19%28.17%28.14%28.19%
No. of Shareholders 19,06620,51922,23723,49423,91024,27924,23524,25728,25027,88927,42527,484

This stock is not held by any mutual fund.

ALTERNATE FEED

Financial ratios

Alternate ratio feed. Source: www.way2wealth.com. The accounting basis and ratio definitions require verification against the source. Values from separate feeds can differ, even for the same period; they are not interchangeable. Use each table’s period labels. Data methodology.

Each card groups related ratios with the same unit. Reporting dates remain visible for every measure; the original ratio table follows the charts.

ALTERNATE RATIO FEED

Profitability ratios

%

Profitability ratios

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Liquidity ratios

Multiple (×)

Liquidity ratios

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Distributions & retention

%

Distributions & retention

%

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Interest coverage

Multiple (×)

Interest coverage

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

ALTERNATE RATIO FEED

Valuation multiples

Multiple (×)

Valuation multiples

Multiple (×)

Switch any metric on or off. Lines show the trend; bars compare the values in each period.

Chart loads as you scroll. Values are available in the table.

Supporting ratio tableAll reported figures · use a chart icon for peer comparison

Key Financial Ratios

MonthMar 25Mar 24Mar 23Mar 22Mar 21
FaceValue 5.005.005.005.005.00
Basic EPS (Rs.) 9.4511.987.226.105.67
Diluted EPS (Rs.) 9.4511.987.226.105.67
Cash EPS (Rs.) 11.1913.709.158.488.68
Book Value[Excl.RevalReserv]/Share (Rs.) 65.0658.1148.1442.6638.04
Book Value[Incl.RevalReserv]/Share (Rs.) 65.0658.1148.1442.6638.04
Dividend / Share (Rs.) 1.502.502.001.751.50
Revenue From Operations / Share (Rs.) 132.01129.11105.2697.1186.20
PBDIT / Share (Rs.) 14.0417.4111.4510.3911.00
PBIT / Share (Rs.) 12.3015.709.528.007.99
PBT / Share (Rs.) 12.1715.639.477.817.69
Net Profit / Share (Rs.) 9.4511.987.226.105.67
PBDIT Margin (%) 10.6313.4810.8710.6912.76
PBIT Margin (%) 9.3112.159.048.239.27
PBT Margin (%) 9.2212.108.998.038.92
Net Profit Margin (%) 7.159.286.856.276.58
Return on Networth / Equity (%) 14.5220.6214.9914.2914.91
Return on Capital Employeed (%) 18.7826.8419.5718.5320.73
Return On Assets (%) 9.3413.478.938.808.54
Total Debt / Equity (X) 0.030.010.000.010.07
Asset Turnover Ratio (%) 1.391.521.401.431.31
Current Ratio (X) 2.112.201.911.981.70
Quick Ratio (X) 1.691.711.461.371.12
Inventory Turnover Ratio (X) 8.838.744.944.364.53
Dividend Payout Ratio (NP) (%) 26.4516.6824.2324.590.00
Dividend Payout Ratio (CP) (%) 22.3314.6019.1117.670.00
Earning Retention Ratio (%) 73.5583.3275.7775.410.00
Cash Earning Retention Ratio (%) 77.6785.4080.8982.330.00
Interest Coverage Ratio (X) 113.62246.74262.7754.1636.88
Interest Coverage Ratio (Post Tax) (X) 77.46170.85166.6632.8020.03
Enterprise Value (Cr.) 736.681223.09392.34417.88446.02
EV / Net Operating Revenue (X) 1.111.890.740.851.03
EV / EBITDA (X) 10.4714.026.848.038.09
MarketCap / Net Operating Revenue (X) 1.131.900.750.881.05
Retention Ratios (%) 73.5483.3175.7675.400.00
Price / BV (X) 2.294.231.652.012.37
Price / Net Operating Revenue (X) 1.131.900.750.881.05
EarningsYield 0.060.040.090.070.06

Competitors

Stock Name ⇩Market Cap ⇩Current Price ⇩High / Low ⇩Stock P/E ⇩Book Value ⇩Dividend Yield ⇩ROCE ⇩ROE ⇩Face Value ⇩
Anuh Pharma Ltd 837 Cr. 83.7 99.5/66.719.0 35.11.79 %14.9 %10.7 % 5.00
Kilitch Drugs (India) Ltd 806 Cr. 230 268/11726.8 80.00.00 %13.4 %10.6 % 10.0
Themis Medicare Ltd 979 Cr. 106 141/65.0 43.30.47 %2.74 %0.41 % 1.00
Wanbury Ltd 650 Cr. 186 360/16215.1 18.10.00 %36.6 %76.5 % 10.0
Bafna Pharmaceuticals Ltd 1,091 Cr. 461 469/94.8140 40.60.00 %11.9 %12.3 % 10.0
Industry Average17,083.24 Cr1,203.8146.72210.850.40%26.16%16.59%6.06

All Competitor Stocks of Anuh Pharma Ltd